3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Radiation Fibrosis Syndrome
2
Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pancreatic Adenocarcinoma
1
Inflammation
1
Fibrosis
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Camurati-Engelmann Syndrome
1
Interventions
ponatinib
3
asciminib
3
nilotinib
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Specimen Handling
2
Melphalan
2
Dasatinib
2
Cyclophosphamide
2
Busulfan
2
venetoclax
1
ruxolitinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Interviews as Topic
1
Imatinib Mesylate
1
Etoposide
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
Losartan
×
90 days
×
Clear all
No trials found.